Organization/Governing Body

Judy E. Garber, M.D., MPH

Judy E. Garber, M.D., MPH has been a Clinical Associate in Medicine at Dana-Farber Cancer Institute and an Associate Physician in Medicine at Brigham and Women's Hospital for over fifteen years. She has been the Director of the Cancer Risk and Prevention Clinic/Clinical Genetics Program at Dana-Farber Cancer Institute for over ten years and is currently a Professor of Medicine at Dana Farber Cancer Institute and Harvard Medical School and Clinical Associate in Medicine, Dana-Farber Cancer Institute, and Associate Physician in Medicine, Brigham and Women's Hospital. Her research interests include Cancer Genetics, Breast Cancer Biology and Treatment, Cancer Chemoprevention and Biomarker Development, and Clinical Epidemiology of Cancer.

Dr. Garber’s research focuses on cancer genetics. Her current research projects include studies with the National Institutes of Health, National Human Genome Research Institute, Breast Cancer Research Foundation, Department of Defense, and Breast Cancer Risk Foundation.

  • “Ovarian Cancer Risk and Hypogonadotropic Hypogonadism”
  • “Plasma Estrogen in Breast Cancer Risk and Prevention” SPORE grant
  • “High Risk Patients and Families” SPORE grant
  • “Prophylactic Surgery in Carriers of BRCA1 and BRCA2 Mutations”
  • “Breast Cancer Prevention in Hodgkins Diseases”
  • “Process and Outcomes of Genetic Testing"
  • “Estrogen Receptor Negative Breast Cancer”
  • “A Randomized Study of the Effects of Tibolone on Bone Density, Menopausal Symptoms and Breast Density in High-Risk Women after Prophylactic Ophorectomy”
  • “Fanconi Anemia FANCD2 Gene Mutations in Young Women with Breast Cancer”
  • “A pilot study of pre-operative platinum therapy: Can tumor DNA-Repair defects in the BRCA1 pathway predict response?”